KR
50
-2
ALLE
48
-5
DIS
43
-2
PDCO
49
3
D
53
2
GPC
43
-2
NI
62
4
LLY
68
3
PLD
48
-8
PYPL
31
-2
MAT
45
-2
MTB
56
-3
CPB
47
-2
NUE
44
3
PRU
59
2
AIZ
69
-2
CFG
58
4
ICE
69
3
VMC
66
3
CAG
47
-3
KR
50
-2
ALLE
48
-5
DIS
43
-2
PDCO
49
3
D
53
2
GPC
43
-2
NI
62
4
LLY
68
3
PLD
48
-8
PYPL
31
-2
MAT
45
-2
MTB
56
-3
CPB
47
-2
NUE
44
3
PRU
59
2
AIZ
69
-2
CFG
58
4
ICE
69
3
VMC
66
3
CAG
47
-3
Financhill
Back

Consolidated Edison Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
45

ED
Consolidated Edison

Last Price:
97.11
Seasonality Move:
3.08%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
42.11
Seasonality Move:
12.29%
Sell
45
Consolidated Edison (ED) is a Sell

Is Consolidated Edison a Buy, Sell or Hold?

  • The current Consolidated Edison [ED] share price is $96.91. The Score for ED is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • ED is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $41.12. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ED Stock Price Chart

What is Consolidated Edison's stock price today?

  • The Consolidated Edison share price today is $96.91
    The current trend is moderately bullish and ED is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $41.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

ED Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.82 Buy
Relative Strength Index (14 RSI): 65.24 Buy
Chaikin Money Flow: -917826 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (90.65 - 96.97) Buy
Bollinger Bands (100): (87.96 - 93.58) Buy

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.38 Sell
Relative Strength Index (14 RSI): 36.17 Sell
Chaikin Money Flow: -526969 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.16 - 45.34) Sell
Bollinger Bands (100): (43.31 - 49.39) Sell

ED Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 97.28 Sell
20-day SMA: 95.05 Buy
50-day SMA: 91.72 Buy
200-day SMA: 90.1 Buy
8-day EMA: 96.83 Buy
20-day EMA: 95.17 Buy
50-day EMA: 92.75 Buy
200-day EMA: 91.16 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.46 Sell
20-day SMA: 42.72 Sell
50-day SMA: 45.61 Sell
200-day SMA: 42.06 Sell
8-day EMA: 41.51 Sell
20-day EMA: 42.79 Sell
50-day EMA: 44.59 Sell
200-day EMA: 44.26 Sell

Consolidated Edison Earnings Growth & ED Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $1.07 per share, an increase this year of $0.28 per share, and an increase next year of $0.29 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.46 per share, an increase next quarter of $0.08 per share, an increase this year of $0.87 per share, and an increase next year of $1.24 per share.

Consolidated Edison Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):